These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16894320)

  • 21. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
    Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
    World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoproliferative small intestinal disease associated with Campylobacter jejuni.
    Lecuit M; Abachin E; Martin A; Poyart C; Pochart P; Suarez F; Bengoufa D; Feuillard J; Lavergne A; Gordon JI; Berche P; Guillevin L; Lortholary O
    N Engl J Med; 2004 Jan; 350(3):239-48. PubMed ID: 14724303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should we suppress the antigenic stimulus in IPSID for lifelong?
    Celik AF; Pamuk GE; Pamuk ON; Uzunismail H; Oktay E; Doğusoy G
    Am J Gastroenterol; 2000 Nov; 95(11):3318-20. PubMed ID: 11095373
    [No Abstract]   [Full Text] [Related]  

  • 24. [Libyan patient with chronic diarrhea].
    Mezger J; Malfertheiner P; Glasmacher A; Breuer TH; Fischer HP; Meybehm M; Kipnowski HJ; Sauerbruch T
    Z Gastroenterol; 1996 Oct; 34(10):699-703. PubMed ID: 9012223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience.
    Akbulut H; Soykan I; Yakaryilmaz F; Icii F; Aksoy F; Haznedaroglu S; Yildirim S
    Cancer; 1997 Jul; 80(1):8-14. PubMed ID: 9210703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alpha heavy chain disease. A Tunisian case].
    Ben Ammar A; Cheikh I; Jouini M; Belkahla N; Fadhel SF; Hager O; Maamouri N; Chaabouni H; Ben Safta Z; Haouet S
    Tunis Med; 2006 Sep; 84(9):581-4. PubMed ID: 17263208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pigmented nails and Strongyloides stercoralis infestation causing clinical worsening in a patient treated for immunoproliferative small intestinal disease: two unusual observations.
    Ghoshal UC; Saha J; Ghoshal U; Ray BK; Santra A; Naik S; Mazumder DN
    J Diarrhoeal Dis Res; 1999 Mar; 17(1):43-5. PubMed ID: 10892497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time.
    AlYamany R; Kharfan-Dabaja MA; Hamadani M; Alshaibani A; Aljurf M
    Curr Oncol; 2022 May; 29(5):3759-3769. PubMed ID: 35621691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoproliferative small intestinal disease versus colonic monoblastic sarcoma in a 2-year-old boy.
    Miron I; Mihăilă D; Aprodu G; Miron L; Plămădeală P; Moisă SM
    Rom J Morphol Embryol; 2009; 50(4):733-8. PubMed ID: 19942975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B; Demeter J; Eros N; Hársing J; Csomor J; Matolcsy A; Bottlik G; Gyori G; Marschalkó M; Kárpáti S
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms.
    Al-Saleem T; Al-Mondhiry H
    Blood; 2005 Mar; 105(6):2274-80. PubMed ID: 15542584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoproliferative small-intestinal disease: follow-up of an alpha-chain negative, lymphoma-free group.
    Gilinsky NH; Novis BH; Mee AS; Wright JP; Price S; Marks IN
    J Clin Gastroenterol; 1983 Oct; 5(5):421-8. PubMed ID: 6415158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
    Micallef IN; Kahl BS; Maurer MJ; Dogan A; Ansell SM; Colgan JP; Geyer S; Inwards DJ; White WL; Habermann TM
    Cancer; 2006 Dec; 107(12):2826-32. PubMed ID: 17099879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment-Resistant Immunoproliferative Small Intestinal Disease (IPSID) Leading to Lymphoma.
    Ismail M; Nasir UM; Elaskandrany MA; Kapila R; Wang W
    Cureus; 2024 Jun; 16(6):e62302. PubMed ID: 39006573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of laparotomy in immunoproliferative small intestinal disease.
    Tabbane F; Mourali N; Cammoun M; Najjar T
    Cancer; 1988 Apr; 61(8):1699-706. PubMed ID: 3349430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoproliferative small intestinal disease presented with ascites and edema.
    Shoaran M; Khodadad A; Mahjoubt F; Kiani MA; Rezaei N
    Acta Clin Croat; 2013 Sep; 52(3):387-90. PubMed ID: 24558774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoproliferative small intestinal disease: a frequently missed diagnosis.
    Puri AS; Kumar M; Khan EM; Pandey R; Aggarwal R; Naik S; Choudhuri G; Naik SR
    Indian J Gastroenterol; 1996 Apr; 15(2):46-8. PubMed ID: 8935933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological features and management of immunoproliferative small intestinal disease and primary small intestinal lymphoma in Pakistan.
    Malik IA; Shamsi Z; Shafquat A; Aziz Z; Shaikh H; Jafri W; Khan MA; Khan AH
    Med Pediatr Oncol; 1995 Nov; 25(5):400-6. PubMed ID: 7674998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heavy Chain Disease of the Small Bowel.
    Bianchi G; Sohani AR
    Curr Gastroenterol Rep; 2018 Jan; 20(1):3. PubMed ID: 29372346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.